Literature DB >> 921087

Tuberculosis after jejunoileal bypass for obesity.

R M Bruce, L Wise.   

Abstract

One hundred patients who underwent jejunoileal bypass for obesity were followed for a mean period of 2 1/2 years. Four patients developed a clinical illness that resembled a systemic form of tuberculosis during the first postoperative year. This incidence exceeds that found in the general population by sixtyfold. Any patient with jejunoileal bypass who develops an illness with accelerated weight loss, enlarged lymph nodes, and unexplained fever with chills should be suspected of having tuberculosis. Aggressive diagnostic measures are required. Treatment with isoniazid and ethambutol at usual doses can be successful, but blood levels should be measured to confirm adequacy until additional information becomes available.

Entities:  

Mesh:

Year:  1977        PMID: 921087     DOI: 10.7326/0003-4819-87-5-574

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Fatal disseminated coccidioidomycosis following an intestinal bypass operation for obesity.

Authors:  W M Johnson
Journal:  West J Med       Date:  1981-10

3.  Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.

Authors:  J P Kampmann; H Klein; B Lumholtz; J E Mølholm Hansen
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

4.  Tuberculosis after jejuno-ileal bypass for morbid obesity.

Authors:  N Werbin
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

Review 5.  Clinical pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

6.  Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany.

Authors:  Christian Gutsfeld; Ioana D Olaru; Oliver Vollrath; Christoph Lange
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

7.  The risk of pulmonary tuberculosis after traumatic brain injury.

Authors:  Hsin-Yueh Liu; Kuang-Ming Liao; Fu-Wen Liang; Yi-Chieh Hung; Jhi-Joung Wang; Te-Chun Shen; Chung-Han Ho
Journal:  Sci Rep       Date:  2021-04-09       Impact factor: 4.379

8.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

9.  Pulmonary Tuberculosis After Gastric Bypass: A Very Rare Complication.

Authors:  Muhammad Israr Ul Haq; Usama Talib; Armghan H Ans; Umer Razzaq; Hassan Mehmood
Journal:  Cureus       Date:  2018-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.